GENE ONLINE|News &
Opinion
Blog

Special
Special HIV
A Cure for HIV Could Be Here Sooner Than You Think – Future of Health
2022-09-16
Special KoreaBio
Scaling up Korea’s Biotech Presence in The Global Value Chain, an Interview with Seung Kyou Lee, Vice President of KoreaBIO
2022-08-31
Special Amazon Care
Amazon Care Scrapped, Making Room for New Telehealth Endeavors
2022-08-25
Go Prime FDA
Mounting Criticisms of FDA’s Accelerated Approval Pathway Could Prompt Changes to the System
2022-08-25
Special Oncology
NIH Provides $23 Million to Fund Telehealth Cancer Care Research
2022-08-22
Special BIOplus2022koreabiotechGlobal Events
BIOPLUS-INTERPHEX Korea 2022: The Now and Tomorrow of Korea’s Biotechnology Industry
2022-08-15
Special BIO Asia-Taiwan
BIO Asia-Taiwan 2022: The Future Of CGT In Taiwan
2022-08-08
Special 2022 Single Cell Sequencing
Single Cell Sequencing – the Current Players
2022-08-04
Special BIO2022
BIO 2022: Addressing Bottlenecks in Gene Therapy
2022-08-03
Special South Korea
Korean Companies Occupying South Korea’s Diverse Biotech Landscape
2022-08-03
Special BIO2022
BIO 2022: Options for Raising Capital in a Down Market
2022-08-01
Special KoreaBio
South Korea’s Biotech Industry：Trends, Landscape, and Clusters Overview
2022-08-01
Special AI
DeepMind’s AlphaFold Predicts Over 200 Million Protein Shapes in AI Breakthrough
2022-08-01
Special BIO Asia-Taiwan
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
2022-07-28
Special BIO Asia-Taiwan
BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka
2022-07-28
1 … 7 8 9 10 11 … 21
LATEST
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top